PLK1 and pulmonary fibrosis: To investigate why selective PLK1 inhibition ameliorated lung fibrosis in bleomycin-treated mice, we next examined whether or not GSK461364 treatment affected the number of inflammatory cells and lymphocyte fractions in BALF.